Clavister Ab · OMXSTO:CLAV
Clavister Ab — Q4 2024 Earnings Presentation
19 slides from Clavister Ab's earnings presentation, Feb 13, 2025
Slide 1: Year-end Report October – December 2024
Year-end Report Clavister Holding AB (publ) October – December 2024
Slide 2: Summary of the Quarter
2 Summary of the Quarter Key Metrics Highlights from the Quarter (MSEK) Q4 2024 Q4 2023 FY 2024 FY 2023 Order Intake 133.7 216.9 259.4 324.6 Net Sales grew by 23 % and ARR grew with 14 %. Order Intake Growth 38.4% 400.9% -20.1% 138.3% Strong Order Intake and substantial deliveries from all busin
Slide 3: Comments by the CEO
3 Comments by the CEO 2024 was a year of growth and clear profit improvement, with In light of the liquidity contribution received from the TO8 OT systems (“operational technology”) are opened up to a strong final quarter where all business operations delivered warrant program - which was subscribed
Slide 4: CEO comments: defence, drones and telecom opportunities
4 Clavister. Deliveries to additional nations will provide revenue specifically for marine applications. The first contract is worth 8 were converted to an order intake of just over 4 MSEK. support from the second half of 2025. MSEK with deliveries that will begin in the first half of 2025. In the s
Slide 5: Comments on Financial Statement
5 Comments on Financial Statement Order Intake Professional services are services related to the Company’s Total order intake for the quarter amounted to 133.7 (216.9) products, for example configuration and optimisation services MSEK, a year-on-year decrease of 38.4 %. The decrease is as well as ad
Slide 6: Annual Recurring Revenue, Gross Margin and Operating Expenses
6 Annual Recurring Revenue Gross Margin and Gross Profit Operating Expenses Annual recurring revenue on 31 December 2024 amounted Gross margin amounted to 76.7 (77.2) %. Total operating expenses (OPEX) amounted to -48.6 (-41.8) to 137.6 (120.3) MSEK, a year-on-year increase with 14.4 %. MSEK, whereo
Slide 7: Operating Result, Shareholders' Equity and Liabilities
7 recurring expenses relate to the ongoing legal dispute with EBIT amounted to -3.2 (-7.1) MSEK. Adjusted EBIT amounted Shareholders’ Equity and Liabilities FortifiedID AB. to -0.7 (-6.8) MSEK. Equity amounted to -84.2 (-228.9) MSEK. Negative group equity is not an issue from a Companies Act perspec
Slide 8: Cash Flow, Liquidity and Planning Assumptions
8 payment received from TO8 and the repayment to the EIB of intellectual property rights owned by the fully owned Proposed Appropriation of Profits for the Parent Company 6 MEUR, which results in a cash outflow of -25.8 MSEK. subsidiary PhenixID AB. Please see the Annual Report 2023 The Board of Dir
Slide 9: Condensed Consolidated Income Statement
9 Condensed Consolidated Income Statement (TSEK) 2024 2023 2024 2023 Oct - Dec Oct - Dec Jan - Dec Jan - Dec Net sales 59,043 48,107 191,663 160,610 Other revenue 2,349 616 6,670 4,431 Total revenue 61,392 48,723 198,333 165,041 COGS -14,224 -11,096 -41,677 -31,944 Gross profit 47,168 37,627 156,656
Slide 10: Condensed Consolidated Balance Sheet
10 Condensed Consolidated Balance Sheet (TSEK) 2024-12-31 2023-12-31 (TSEK) 2024-12-31 2023-12-31 Assets Equity and liabilities Non-current assets Equity Goodwill 66,697 66,697 Equity -84,185 -228,882 Intangible assets 110,043 108,923 Total equity -84,185 -228,882 Property, Plant & Equipment 1,222 6
Slide 11: Condensed Statement of Changes in Equity
11 Condensed Statement of Changes in Equity (TSEK) 2024 2023 2024 2023 Oct - Dec Oct - Dec Jan - Dec Jan - Dec Equity, beginning of period -125,387 -222,070 -228,882 -163,536 Cash issue 45,755 0 215,369 0 Issue expenses 0 0 -28,082 0 Non-registered issue 0 0 588 0 Share-based payments according to I
Slide 12: Condensed Consolidated Cash Flow Statement
12 Condensed Consolidated Cash Flow Statement (TSEK) 2024 2023 2024 2023 Okt - Dec Okt - Dec Jan - Dec Jan - Dec Profit (loss) before taxes -17,562 -6,974 -56,139 -65,503 Reversal of depreciation and write-downs 11,303 13,586 44,285 48,295 Other adjustments for non-cash items, etc * 3,163 -5,604 19,
Slide 13: Condensed Income Statement for Parent Company
13 Condensed Income Statement for Parent Company Clavister Holding AB (TSEK) 2024 2023 2024 2023 Oct - Dec Oct - Dec Jan - Dec Jan - Dec Net sales 2 251 2 250 9 005 9 004 Total revenue 2 251 2 250 9 005 9 004 Staff costs -3 622 -3 527 -12 497 -13 396 Other external costs -2 777 -899 -6 081 -5 435 EB
Slide 14: Condensed Balance Sheet for Parent Company
14 Condensed Balance Sheet for Parent Company Clavister Holding AB (TSEK) 2024-12-31 2023-12-31 Assets Fixed assets Shares in group companies 475,155 462,274 Receivables from group companies 19,900 8,000 Total fixed assets 495,055 470,274 Current assets Current receivables 723 457 Cash and bank bala
Slide 15: Notes
15 Noter Note 1 Accounting Policies according to the Black & Scholes model and has therefore not The consolidated financial statements have been prepared in % of total affected the Group’s Income statement by any charges. accordance with the International Financial Reporting Number of shares number
Slide 16: Notes: Convertible Loan, Pledged Assets, Alternative Performance Measures
16 Note 5 Pledged Assets Note 7 Alternative Performance Measures Clavister uses various key figures, including alternative Convertible Loan performance measures (APMs), for internal analysis purposes GROUP The issued convertible loan amounts to 10 MSEK and matures and for external communication of t
Slide 17: Note 8 Definitions
17 Note 8 Definitions Cash OPEX – Operational expenditures, including capitalized described in the annual report 2022). Adjustments of the net R&D, with a cash-flow impact. order book value may occur from time to time due to for Adjusted EBIT – EBIT adjusted for non-recurring expenses. instance curr
Slide 18: Note 9 Financial Metrics
18 Note 9 Financial Metrics TSEK 2024 2023 2024 2023 Oct - Dec Oct - Dec Jan - Dec Jan - Dec Net sales (TSEK) 59,043 48,107 191,663 160,610 Total revenue (TSEK) 61,392 48,723 198,333 165,041 Gross profit (TSEK) 47,168 37,628 156,656 133,097 Gross margin (%) 76.8% 77.2% 79.0% 80.6% EBITDA (TSEK) 8,10
Slide 19: Report Information
19 Report Information Financial Calendar Release of Annual Interim Report Annual General Interim Report report Jan - Mar 2025 Meeting Apr- June 2025 28 April 2025 8 May 2025 19 May 2025 21 Aug 2025 The Share Any forward-looking statements in this report Exchange: Nasdaq First North are based on Clav
Clavister Holding AB (publ.) — Q4 2024 Earnings Presentation on 6ix